Global pharmaceutical majors agree to work together to hit carbon emission goals

With the pharmaceutical industry contributing as much as 4-5% of global carbon emissions, it's great to see some of the leaders in the industry doing their part. Seven of the biggest have teamed up to pledge to work together to reduce carbon emissions in supply chains, health-care delivery and clinical trials.  A joint effort that will enable the industry to achieve far more toward reducing industry emissions than individual companies could alone.

2023-05-17T21:23:00+10:30March 29, 2023|

Reverse logistics management, critical to clinical trials.

Good planning is paramount in the execution of Clinical Trials and so are the reverse logistics. Effective clinical trial reverse logistics are vital to ensure the smooth progression of the trial, equipment is maintained and environmental waste is minimised. Read more to understand the planning considerations necessary or contact BS3 to discuss your reverse logistics needs further.

2023-03-20T14:23:46+10:30March 20, 2023|

MDMA & Psilocybin to be rescheduled from S9 to S8

3rd February 2023, the Therapeutic Goods Administration (TGA) announced that from the 1st July 2023, medical use of MDMA and Psilocybin will be rescheduled from Schedule 9 (prohibited substances) to Schedule 8 (controlled medicines) of the Poisons Standard. Which will enable authorised psychiatrists to prescribe these substances for treatment-resistant depression and treatment resistant post-traumatic stress disorder.

2023-03-20T14:24:54+10:30February 10, 2023|

Medical cannabis prescriptions surge in Australia

The first in depth study of Australia's medicinal cannabis program shows huge prescription growth over the last 2 years in Australia as more doctors begin to prescribe it for pain relief and management of chronic illness. More than 248,000 prescriptions have been approved over the past five years with 85% of that figure given out post January 2020.

2023-03-20T14:25:46+10:30November 11, 2022|

Aust Govt investing in medical research grants through MRFF

On the 28 September 2022, World Heart Day, the Albanese Government announced it would invest $33.6 million in medical research grants for 41 projects to help reduce the number of Australians affected by heart disease and stroke. The grants are part of $156.7 million for 93 innovative medical research projects to improve the health and wellbeing of Australians through the Medical Research Future Fund (MRFF).

2023-03-20T16:18:36+10:30October 25, 2022|
Go to Top